These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis. Crotti C; Biggioggero M; Becciolini A; Agape E; Favalli EG Expert Opin Investig Drugs; 2019 Jul; 28(7):573-581. PubMed ID: 31208237 [No Abstract] [Full Text] [Related]
3. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507 [TBL] [Abstract][Full Text] [Related]
4. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date. Crotti C; Raimondo MG; Becciolini A; Biggioggero M; Favalli EG Drug Des Devel Ther; 2017; 11():211-223. PubMed ID: 28144129 [TBL] [Abstract][Full Text] [Related]
5. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation. Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288 [TBL] [Abstract][Full Text] [Related]
7. Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis. Di Franco M; Gerardi MC; Lucchino B; Conti F Core Evid; 2014; 9():41-8. PubMed ID: 24648832 [TBL] [Abstract][Full Text] [Related]
8. GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential. Hamilton JA Expert Rev Clin Immunol; 2015 Apr; 11(4):457-65. PubMed ID: 25748625 [TBL] [Abstract][Full Text] [Related]
9. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha. Haworth C; Brennan FM; Chantry D; Turner M; Maini RN; Feldmann M Eur J Immunol; 1991 Oct; 21(10):2575-9. PubMed ID: 1915559 [TBL] [Abstract][Full Text] [Related]
10. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis. Cook AD; Turner AL; Braine EL; Pobjoy J; Lenzo JC; Hamilton JA Arthritis Rheum; 2011 Aug; 63(8):2340-51. PubMed ID: 21809323 [TBL] [Abstract][Full Text] [Related]
11. Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. Nair JR; Edwards SW; Moots RJ Expert Opin Biol Ther; 2012 Dec; 12(12):1661-8. PubMed ID: 23094973 [TBL] [Abstract][Full Text] [Related]
12. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis. van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345 [TBL] [Abstract][Full Text] [Related]
13. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Greven DE; Cohen ES; Gerlag DM; Campbell J; Woods J; Davis N; van Nieuwenhuijze A; Lewis A; Heasmen S; McCourt M; Corkill D; Dodd A; Elvin J; Statache G; Wicks IP; Anderson IK; Nash A; Sleeman MA; Tak PP Ann Rheum Dis; 2015 Oct; 74(10):1924-30. PubMed ID: 24936585 [TBL] [Abstract][Full Text] [Related]
14. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Huizinga TW; Batalov A; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E Arthritis Res Ther; 2017 Mar; 19(1):53. PubMed ID: 28274253 [TBL] [Abstract][Full Text] [Related]
15. Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients. Makris A; Adamidi S; Koutsianas C; Tsalapaki C; Hadziyannis E; Vassilopoulos D Front Immunol; 2017; 8():1967. PubMed ID: 29375580 [TBL] [Abstract][Full Text] [Related]
16. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. Alvaro-Gracia JM; Zvaifler NJ; Brown CB; Kaushansky K; Firestein GS J Immunol; 1991 May; 146(10):3365-71. PubMed ID: 2026869 [TBL] [Abstract][Full Text] [Related]
17. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model. Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731 [TBL] [Abstract][Full Text] [Related]
18. Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF Bystrom J; Clanchy FI; Taher TE; Al-Bogami MM; Muhammad HA; Alzabin S; Mangat P; Jawad AS; Williams RO; Mageed RA Clin Rev Allergy Immunol; 2017 Oct; 53(2):265-276. PubMed ID: 28488248 [TBL] [Abstract][Full Text] [Related]
19. Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis. Kondo N; Kuroda T; Kobayashi D Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681582 [TBL] [Abstract][Full Text] [Related]